Josh Blacher

CFO

Equibles does not estimate personal net worth.

Get an email with a short summary when Imunon, Inc. publishes a filing, an earnings call transcript or a press release.

About Josh Blacher

Josh Blacher is recorded as CFO at Imunon, Inc. (IMNN) since July 1, 2026. Imunon, Inc. reported in an 8-K filed June 30, 2026 that Josh Blacher was appointed interim Chief Financial Officer, effective July 1, 2026. Josh Blacher has spoken on 1 earnings call across 1 company, most recently for Imunon, Inc. on August 11, 2026. Imunon, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Imunon, Inc. includes Corinne Le Goff (CEO and Board Member), Michael Tardugno (CEO and Chairman), Stacy Lindborg (CEO and Board Member) and 7 others.

“As a result of Mr. Church's retirement, effective July 1, 2026, the Company appointed Josh Blacher to serve as the Company's new interim Chief Financial Officer under a master services agreement (the "Agreement"), dated June 24, 2026, between the Company and Danforth Health, Inc., a financial advisory services firm ("Danforth").”

Imunon, Inc. Form 8-K, filed June 30, 2026 · Read the filing

Josh Blacher on recent calls

“Details of Immunon's second quarter 2026 financial results are included in the press release we issued this morning and our Form 10Q, which we filed before the market opened this morning. research and development expenses for the second quarter were 1.5 million compared with 1.2 million for the same period last year…”

CFO, Imunon, Inc. Q2 FY2026 Earnings Call · August 11, 2026